Competency information
Details
Inform clinicians (and patients where applicable) on the specifications of components, blood safety, risk benefit of transfusion and blood supply issues.
Considerations
- Methods used to prepare blood components and products within a defined quality and legislative framework, including preparation, validation, labelling, shelf life quality monitoring and storage of:
- red cells
- platelets
- fresh frozen plasma
- cryoprecipitate
- washed cells
- irradiated blood components.
- Emerging technologies in blood component preparation and therapy such as pathogen inactivation.
- Donor selection and the measures taken by the blood service to prevent transfusion transmitted infections (TTIs) and the methods used to test for:
- HIV
- HBV
- HCV
- syphilis
- HTLV I/II
- other infective agents
- emerging pathogens.
- Algorithms to assess the acceptability of donated blood and donor suitability based on screening and follow-up tests for transfusion-transmissible infections.
- The time frame in which blood components with special requirements can reasonably be expected to be available.
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 6 | Outcome Work with specialist blood transfusion services to provide safe transfusion support for patients and be able to inform clinicians on blood safety issues. |